LABRHA is supporting Eurovisco by organizing its annual board since 2014. We are proud to be Eurovisco’s partner. Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group Thierry Conrozier 1 , Raghu Raman 2 , Xavier Chevalier 3...
Read moreLABRHA is supporting Eurovisco by organizing its annual board since 2014. We are proud to be Eurovisco’s partner. Abstract Objectives: Hyaluronic acid viscosupplementation is a commonly used intra-articular treatment for osteoarthritis (OA). Some recent preclinical and clinical trials have demonstrated a...
Read moreLABRHA is supporting Eurovisco by organizing its annual board since 2014. We are proud to be Eurovisco’s partner. Abstract Objectives The 3 aims of the work were to identify population subgroups that can benefit the most from viscosupplementation (VS), to...
Read more
On September 2023 in Lyon, took place the 2nd Applied Rheumatology Congress, organised by Labrha. This year’s subject was : Osteoarthritis today and tomorrow ! We are happy to have hosted European experts and had the pleasure to listen to Read more…
On early September 2023, Eurovisco held its annual consensus meeting gathering Europeans osteoarthritis experts. This year’s aim was to determine the imaging and clinical criteria that influence the success rate of treatment of knee osteoarthritis by injection of an HA-based Read more…
